Treace Medical Concepts (TMCI) Income from Continuing Operations (2020 - 2026)
Treace Medical Concepts (TMCI) posted Income from Continuing Operations of 20846000.0 for Q1 2026, down 199.47% on a QoQ basis from 6961000.0 in Q4 2025, and down 29.87% year-over-year from 29722863.03 in Q1 2025.
Treace Medical Concepts (TMCI) Income from Continuing Operations (2020 - 2026) Analysis & Trends
Treace Medical Concepts' Income from Continuing Operations history runs 7 years deep, the most recent figure standing at 20846000.0 for Q1 2026.
- Quarterly Income from Continuing Operations fell 29.87% year-over-year to 20846000.0 in Q1 2026, while the trailing twelve-month figure through Mar 2026 was 61707000.0 (down 15.08% YoY) and the FY2025 annual result came in at 108048000.0, down 13.84% from the prior year.
- Income from Continuing Operations was 20846000.0 for Q1 2026 at Treace Medical Concepts, down from 6961000.0 in the prior quarter.
- Across five years, Income from Continuing Operations topped out at 873000.0 in Q4 2024 and bottomed at 34890000.0 in Q1 2022.
- A 5-year average of 14718235.29 and a median of 15380000.0 in 2024 frame the typical range for Income from Continuing Operations.
- Annual changes were most pronounced in 2022 — Income from Continuing Operations soared 93.94% — and 2025, when it plunged 697.37%.
- Treace Medical Concepts' Income from Continuing Operations stood at 4055000.0 in 2022, then plunged by 57.26% to 6377000.0 in 2023, then surged by 86.31% to 873000.0 in 2024, then plunged by 697.37% to 6961000.0 in 2025, then slumped by 199.47% to 20846000.0 in 2026.
- Business Quant data shows TMCI's Income from Continuing Operations at 20846000.0 in Q1 2026, 6961000.0 in Q4 2025, and 16380000.0 in Q3 2025.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Income (Continuing) (Qtr) |
|---|---|---|---|---|---|
| 1 | Abbott Laboratories | 201.40 Bn | 194.75 Bn | 6.27 Bn | 1.08 Bn |
| 2 | Stryker | 122.29 Bn | 119.41 Bn | 3.81 Bn | 745.00 Mn |
| 3 | Medtronic | 105.01 Bn | 96.40 Bn | 6.41 Bn | 1.26 Bn |
| 4 | Boston Scientific | 64.81 Bn | 63.59 Bn | 3.61 Bn | 1.34 Bn |
| 5 | Edwards Lifesciences | 55.28 Bn | 51.60 Bn | 1.29 Bn | 380.70 Mn |
| 6 | Dexcom | 29.06 Bn | 27.94 Bn | 750.30 Mn | 199.50 Mn |
| 7 | Koninklijke Philips | 29.02 Bn | 25.93 Bn | 2.07 Bn | 273.95 Mn |
| 8 | GE HealthCare Technologies | 28.27 Bn | 26.20 Bn | 1.98 Bn | 411.00 Mn |
| 9 | Smith & Nephew | 25.80 Bn | 25.22 Bn | - | - |
| 10 | Treace Medical Concepts | 261.60 Mn | 209.75 Mn | 37.41 Mn | -20.85 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | -20.85 Mn |
| Dec 31, 2025 | -6.96 Mn |
| Sep 30, 2025 | -16.38 Mn |
| Jun 30, 2025 | -17.52 Mn |
| Mar 31, 2025 | -16.05 Mn |
| Dec 31, 2024 | -873,000.00 |
| Sep 30, 2024 | -15.38 Mn |
| Jun 30, 2024 | -21.32 Mn |
| Mar 31, 2024 | -18.75 Mn |
| Dec 31, 2023 | -6.38 Mn |
| Sep 30, 2023 | -17.54 Mn |
| Jun 30, 2023 | -12.37 Mn |
| Mar 31, 2023 | -13.58 Mn |
| Dec 31, 2022 | -4.06 Mn |
| Sep 30, 2022 | -12.09 Mn |
| Jun 30, 2022 | -15.23 Mn |
| Mar 31, 2022 | -34.89 Mn |
| Dec 31, 2021 | -6.58 Mn |
| Sep 30, 2021 | -199.46 Mn |
| Jun 30, 2021 | -236.75 Mn |